
Article
Expanding investor confidence: The strategic value of Patient Reported Outcomes (PROs) in biotech fundraising
For biotech companies engaged in the clinical development of a therapeutic innovation, securing investor trust is as critical as demonstrating the scientific value of their molecule. One powerful yet underleveraged...